LIVN logo

LivaNova (LIVN) EBITDA

Annual EBITDA

$38.48 M
+$7.58 M+24.52%

December 31, 2023

Summary

Performance

1-Year Change

+24.52%

3-Year Change

+117.04%

5-Year Change

+122.95%

15-Year Change

-81.84%

LIVN EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

84.78%
LIVN annual EBITDA is higher than 84.78% of companies in Healthcare sector

High & Low

All-time High

$211.87 M
LIVN annual EBITDA is currently -81.84% below its historical high of $211.87 million

3-Year Low

-$6.33 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
LIVN previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 25, 2025
LIVN next annual earnings announcement is scheduled for Feb 25, 2025

OtherLIVNprofitabilitymetrics:

Annual Revenue

$1.15 B
LIVN annual revenue is $1.15 billion

Annual Net Income

$17.55 M
LIVN annual net profit is $17.55 million

Annual EBIT

-$22.37 M
LIVN annual earnings before interest & taxes is -$22.37 million

Annual EPS

$0.32
LIVN annual earnings per share is $0.32

Quarterly EBITDA

$73.45 M
+$24.03 M+48.63%

September 30, 2024

Summary

Performance

3-Month Change

+48.63%

1-Year Change

+161.42%

3-Year Change

+619.91%

5-Year Change

+53.53%

LIVN Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

88.84%
LIVN quarterly EBITDA is higher than 88.84% of companies in Healthcare sector

High & Low

All-time High

$85.52 M
LIVN quarterly EBITDA is currently -14.12% below its historical high of $85.52 million

3-Year Low

-$79.73 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
LIVN previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 25, 2025
LIVN next earnings announcement is scheduled for Feb 25, 2025

OtherLIVNprofitabilitymetrics:

Quarterly Revenue

$318.12 M
LIVN quarterly revenue is $318.12 million

Quarterly Net Income

$32.95 M
LIVN quarterly net profit is $32.95 million

Quarterly EBIT

$60.32 M
LIVN quarterly earnings before interest & taxes is $60.32 million

Quarterly EPS

$0.60
LIVN quarterly earnings per share is $0.60

TTM EBITDA

$54.89 M
+$45.35 M+475.29%

September 30, 2024

Summary

Performance

3-Month Change

+475.29%

1-Year Change

-59.69%

3-Year Change

+118.68%

5-Year Change

+160.79%

LIVN TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

84.06%
LIVN TTM EBITDA is higher than 84.06% of companies in Healthcare sector

High & Low

All-time High

$229.43 M
LIVN TTM EBITDA is currently -76.07% below its historical high of $229.43 million

3-Year Low

-$6.33 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
LIVN previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 25, 2025
LIVN next earnings announcement is scheduled for Feb 25, 2025

OtherLIVNprofitabilitymetrics:

TTM Revenue

$1.24 B
LIVN TTM revenue is $1.24 billion

TTM Net Income

$23.68 M
LIVN TTM net profit is $23.68 million

TTM EBIT

$458.00 K
LIVN TTM earnings before interest & taxes is $458.00 thousand

TTM EPS

$0.42
LIVN TTM earnings per share is $0.42

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

$38.48 M
LIVN annual EBITDA is $38.48 million

Annual Net Income

$17.55 M
LIVN annual net profit is $17.55 million

Annual Interest Expense

$58.85 M
LIVN annual interest expense is $58.85 million

Annual Income Tax

-$98.88 M
LIVN annual income tax is -$98.88 million

Annual D&A

$60.86 M
LIVN annual depreciation & amortization is $60.86 million

LIVN EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+24.5%+161.4%-59.7%
3 y3 years+117.0%+619.9%+118.7%
5 y5 years+123.0%+53.5%+160.8%

LIVN EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+707.7%at high+192.1%-59.7%+966.8%
5 y5-yearat high+117.0%at high+127.6%-59.7%+118.7%
alltimeall time-81.8%+117.0%-14.1%+127.6%-76.1%+118.7%

LivaNova EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
$73.45 M(+48.6%)
$54.89 M(+475.3%)
Jun 2024
-
$49.41 M(-1056.2%)
$9.54 M(-297.0%)
Mar 2024
-
-$5.17 M(-91.8%)
-$4.84 M(-112.6%)
Dec 2023
$38.48 M(+24.5%)
-$62.80 M(-323.5%)
$38.48 M(-71.7%)
Sep 2023
-
$28.09 M(-19.8%)
$136.17 M(+380.5%)
Jun 2023
-
$35.03 M(-8.2%)
$28.34 M(-30.7%)
Mar 2023
-
$38.16 M(+9.4%)
$40.91 M(+32.4%)
Dec 2022
$30.90 M(-588.0%)
$34.89 M(-143.8%)
$30.90 M(+77.4%)
Sep 2022
-
-$79.73 M(-267.5%)
$17.42 M(-79.0%)
Jun 2022
-
$47.60 M(+69.1%)
$83.03 M(+425.7%)
Mar 2022
-
$28.15 M(+31.5%)
$15.79 M(-349.4%)
Dec 2021
-$6.33 M(-97.2%)
$21.40 M(-251.5%)
-$6.33 M(-97.8%)
Sep 2021
-
-$14.13 M(-28.0%)
-$293.82 M(+12.2%)
Jun 2021
-
-$19.63 M(-425.8%)
-$261.92 M(+9.6%)
Mar 2021
-
$6.03 M(-102.3%)
-$238.88 M(+5.8%)
Dec 2020
-$225.87 M(+150.1%)
-$266.08 M(-1597.4%)
-$225.87 M(+160.3%)
Sep 2020
-
$17.77 M(+421.7%)
-$86.78 M(+53.0%)
Jun 2020
-
$3.41 M(-82.1%)
-$56.71 M(-17.0%)
Mar 2020
-
$19.04 M(-115.0%)
-$68.32 M(-24.3%)
Dec 2019
-$90.30 M(-46.1%)
-$127.00 M(-365.5%)
-$90.30 M(-59.6%)
Sep 2019
-
$47.84 M(-683.3%)
-$223.67 M(-14.0%)
Jun 2019
-
-$8.20 M(+179.1%)
-$260.01 M(+22.7%)
Mar 2019
-
-$2.94 M(-98.9%)
-$211.94 M(+26.4%)
Dec 2018
-$167.68 M(-179.1%)
-$260.37 M(-2364.5%)
-$167.68 M(-236.7%)
Sep 2018
-
$11.50 M(-71.2%)
$122.67 M(-25.3%)
Jun 2018
-
$39.87 M(-3.5%)
$164.16 M(-21.8%)
Mar 2018
-
$41.32 M(+37.8%)
$209.81 M(-1.0%)
Dec 2017
$211.87 M(+74.2%)
$29.99 M(-43.4%)
$211.87 M(-7.7%)
Sep 2017
-
$52.98 M(-38.0%)
$229.43 M(+2.6%)
Jun 2017
-
$85.52 M(+97.1%)
$223.72 M(+24.9%)
Mar 2017
-
$43.38 M(-8.7%)
$179.19 M(+47.3%)
Dec 2016
$121.64 M(+26.6%)
$47.55 M(+0.6%)
$121.64 M(+64.2%)
Sep 2016
-
$47.27 M(+15.3%)
$74.10 M(+2872.3%)
Jun 2016
-
$40.99 M(-389.5%)
$2.49 M(-75.8%)
Mar 2016
-
-$14.16 M(-41.8%)
$10.31 M(-85.1%)
Sep 2015
-
-$24.34 M(-183.0%)
$69.32 M(-42.9%)
Jul 2015
-
$29.31 M(+50.3%)
$121.36 M(+31.8%)
Jun 2015
-
$19.50 M(-1.1%)
$92.06 M(-4.2%)
Apr 2015
-
$19.72 M(-21.5%)
$96.12 M(+2.5%)
Apr 2015
$96.12 M(+12.4%)
-
-
Jan 2015
-
$25.13 M(-9.3%)
$93.75 M(+2.8%)
Oct 2014
-
$27.71 M(+17.6%)
$91.16 M(+5.2%)
Jul 2014
-
$23.56 M(+35.9%)
$86.69 M(+1.4%)
Apr 2014
$85.53 M(+6.9%)
$17.34 M(-23.1%)
$85.53 M(-1.6%)
Jan 2014
-
$22.55 M(-3.0%)
$86.89 M(+1.1%)
Oct 2013
-
$23.24 M(+3.7%)
$85.91 M(+2.2%)
Jul 2013
-
$22.40 M(+19.8%)
$84.05 M(+5.0%)
Apr 2013
$80.03 M(+21.9%)
$18.71 M(-13.2%)
$80.03 M(-0.8%)
Jan 2013
-
$21.57 M(+0.9%)
$80.66 M(+4.9%)
Oct 2012
-
$21.37 M(+16.2%)
$76.91 M(+7.7%)
Jul 2012
-
$18.39 M(-4.9%)
$71.39 M(+8.7%)
Apr 2012
$65.65 M(+25.4%)
$19.34 M(+8.5%)
$65.65 M(+8.3%)
Jan 2012
-
$17.82 M(+12.5%)
$60.60 M(+9.7%)
Oct 2011
-
$15.84 M(+25.2%)
$55.24 M(+4.8%)
Jul 2011
-
$12.65 M(-11.5%)
$52.72 M(+0.7%)
Apr 2011
$52.36 M(+23.1%)
$14.29 M(+14.8%)
$52.36 M(+2.9%)
Jan 2011
-
$12.46 M(-6.5%)
$50.89 M(+5.1%)
Oct 2010
-
$13.32 M(+8.4%)
$48.42 M(+5.9%)
Jul 2010
-
$12.28 M(-4.3%)
$45.74 M(+7.6%)
Apr 2010
$42.52 M(+28.8%)
$12.83 M(+28.5%)
$42.52 M(+13.3%)
Jan 2010
-
$9.99 M(-6.1%)
$37.54 M(-3.3%)
Oct 2009
-
$10.64 M(+17.3%)
$38.81 M(+17.4%)
Jul 2009
-
$9.07 M(+15.4%)
$33.05 M(+19.7%)
Apr 2009
$33.02 M
$7.85 M(-30.2%)
$27.62 M(+17.0%)
DateAnnualQuarterlyTTM
Jan 2009
-
$11.25 M(+130.7%)
$23.61 M(+72.9%)
Oct 2008
-
$4.88 M(+34.3%)
$13.66 M(+120.0%)
Jul 2008
-
$3.63 M(-5.7%)
$6.21 M(-245.4%)
Apr 2008
-$4.27 M(-90.5%)
$3.85 M(+196.5%)
-$4.27 M(-75.1%)
Jan 2008
-
$1.30 M(-150.5%)
-$17.16 M(-52.4%)
Oct 2007
-
-$2.57 M(-62.4%)
-$36.06 M(-19.1%)
Jul 2007
-
-$6.85 M(-24.3%)
-$44.60 M(-1.0%)
Apr 2007
-$45.04 M(-17.7%)
-$9.04 M(-48.6%)
-$45.04 M(+18.1%)
Jan 2007
-
-$17.60 M(+58.4%)
-$38.14 M(+11.0%)
Oct 2006
-
-$11.11 M(+52.5%)
-$34.37 M(-20.6%)
Jul 2006
-
-$7.28 M(+240.0%)
-$43.28 M(-19.5%)
Apr 2006
-$54.74 M(+513.8%)
-$2.14 M(-84.5%)
-$53.74 M(-6.5%)
Jan 2006
-
-$13.83 M(-30.9%)
-$57.46 M(+31.3%)
Oct 2005
-
-$20.01 M(+12.7%)
-$43.76 M(+76.4%)
Jul 2005
-
-$17.75 M(+203.3%)
-$24.80 M(+178.1%)
Apr 2005
-$8.92 M(-176.8%)
-$5.85 M(+4239.0%)
-$8.92 M(+226.7%)
Jan 2005
-
-$134.90 K(-87.3%)
-$2.73 M(-112.6%)
Oct 2004
-
-$1.06 M(-43.4%)
$21.69 M(-22.1%)
Jul 2004
-
-$1.87 M(-657.7%)
$27.86 M(-17.1%)
Apr 2004
$11.61 M(+18.5%)
$335.60 K(-98.6%)
$33.60 M(-12.9%)
Jan 2004
-
$24.29 M(+375.7%)
$38.60 M(+101.0%)
Oct 2003
-
$5.11 M(+31.8%)
$19.21 M(+16.4%)
Jul 2003
-
$3.87 M(-27.3%)
$16.49 M(+68.2%)
Apr 2003
$9.80 M(-142.8%)
$5.33 M(+8.9%)
$9.80 M(-800.5%)
Jan 2003
-
$4.90 M(+104.6%)
-$1.40 M(-87.3%)
Oct 2002
-
$2.39 M(-185.0%)
-$11.06 M(-43.4%)
Jul 2002
-
-$2.82 M(-52.0%)
-$19.56 M(-14.7%)
Apr 2002
-$22.91 M(+40.6%)
-$5.87 M(+23.3%)
-$22.91 M(+17.4%)
Jan 2002
-
-$4.76 M(-21.9%)
-$19.51 M(-24.9%)
Oct 2001
-
-$6.10 M(-1.1%)
-$25.97 M(+25.2%)
Jul 2001
-
-$6.17 M(+149.6%)
-$20.75 M(+25.1%)
Apr 2001
-$16.30 M(+328.8%)
-
-
Mar 2001
-
-$2.47 M(-78.0%)
-$16.60 M(+18.0%)
Dec 2000
-
-$11.22 M(+1170.4%)
-$14.06 M(+363.1%)
Sep 2000
-
-$883.50 K(-56.2%)
-$3.04 M(-19.1%)
Jun 2000
-$3.80 M(-69.8%)
-$2.01 M(-3313.6%)
-$3.75 M(+75.0%)
Mar 2000
-
$62.70 K(-131.3%)
-$2.14 M(-59.1%)
Dec 1999
-
-$200.00 K(-87.5%)
-$5.24 M(-42.0%)
Sep 1999
-
-$1.60 M(+293.6%)
-$9.04 M(-28.5%)
Jun 1999
-$12.60 M(-18.7%)
-$406.50 K(-86.6%)
-$12.64 M(-27.5%)
Mar 1999
-
-$3.03 M(-24.1%)
-$17.43 M(+5.0%)
Dec 1998
-
-$4.00 M(-23.1%)
-$16.60 M(+7.1%)
Sep 1998
-
-$5.20 M(0.0%)
-$15.50 M(0.0%)
Jun 1998
-$15.50 M(+39.6%)
-$5.20 M(+136.4%)
-$15.50 M(+14.0%)
Mar 1998
-
-$2.20 M(-24.1%)
-$13.60 M(-5.6%)
Dec 1997
-
-$2.90 M(-44.2%)
-$14.40 M(+2.1%)
Sep 1997
-
-$5.20 M(+57.6%)
-$14.10 M(+30.6%)
Jun 1997
-$11.10 M(+8.8%)
-$3.30 M(+10.0%)
-$10.80 M(+0.9%)
Mar 1997
-
-$3.00 M(+15.4%)
-$10.70 M(+5.9%)
Dec 1996
-
-$2.60 M(+36.8%)
-$10.10 M(+1.0%)
Sep 1996
-
-$1.90 M(-40.6%)
-$10.00 M(-2.9%)
Jun 1996
-$10.20 M(+34.2%)
-$3.20 M(+33.3%)
-$10.30 M(+7.3%)
Mar 1996
-
-$2.40 M(-4.0%)
-$9.60 M(+7.9%)
Dec 1995
-
-$2.50 M(+13.6%)
-$8.90 M(+9.9%)
Sep 1995
-
-$2.20 M(-12.0%)
-$8.10 M(+6.6%)
Jun 1995
-$7.60 M(+22.6%)
-$2.50 M(+47.1%)
-$7.60 M(+18.8%)
Mar 1995
-
-$1.70 M(0.0%)
-$6.40 M(+4.9%)
Dec 1994
-
-$1.70 M(0.0%)
-$6.10 M(0.0%)
Sep 1994
-
-$1.70 M(+30.8%)
-$6.10 M(+1.7%)
Jun 1994
-$6.20 M(+17.0%)
-$1.30 M(-7.1%)
-$6.00 M(-6.3%)
Mar 1994
-
-$1.40 M(-17.6%)
-$6.40 M(+6.7%)
Dec 1993
-
-$1.70 M(+6.3%)
-$6.00 M(+39.5%)
Sep 1993
-
-$1.60 M(-5.9%)
-$4.30 M(+59.3%)
Jun 1993
-$5.30 M
-$1.70 M(+70.0%)
-$2.70 M(+170.0%)
Mar 1993
-
-$1.00 M
-$1.00 M

FAQ

  • What is LivaNova annual EBITDA?
  • What is the all time high annual EBITDA for LivaNova?
  • What is LivaNova annual EBITDA year-on-year change?
  • What is LivaNova quarterly EBITDA?
  • What is the all time high quarterly EBITDA for LivaNova?
  • What is LivaNova quarterly EBITDA year-on-year change?
  • What is LivaNova TTM EBITDA?
  • What is the all time high TTM EBITDA for LivaNova?
  • What is LivaNova TTM EBITDA year-on-year change?

What is LivaNova annual EBITDA?

The current annual EBITDA of LIVN is $38.48 M

What is the all time high annual EBITDA for LivaNova?

LivaNova all-time high annual EBITDA is $211.87 M

What is LivaNova annual EBITDA year-on-year change?

Over the past year, LIVN annual EBITDA has changed by +$7.58 M (+24.52%)

What is LivaNova quarterly EBITDA?

The current quarterly EBITDA of LIVN is $73.45 M

What is the all time high quarterly EBITDA for LivaNova?

LivaNova all-time high quarterly EBITDA is $85.52 M

What is LivaNova quarterly EBITDA year-on-year change?

Over the past year, LIVN quarterly EBITDA has changed by +$45.35 M (+161.42%)

What is LivaNova TTM EBITDA?

The current TTM EBITDA of LIVN is $54.89 M

What is the all time high TTM EBITDA for LivaNova?

LivaNova all-time high TTM EBITDA is $229.43 M

What is LivaNova TTM EBITDA year-on-year change?

Over the past year, LIVN TTM EBITDA has changed by -$81.28 M (-59.69%)